HomeSGMO • NASDAQ
add
Sangamo Therapeutics Inc
Nakaraang pagsara
$1.22
Sakop ng araw
$1.12 - $1.25
Sakop ng taon
$0.30 - $3.18
Market cap
243.07M USD
Average na Volume
9.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 49.41M | 425.77% |
Gastos sa pagpapatakbo | 8.65M | -37.86% |
Net na kita | 10.67M | 110.25% |
Net profit margin | 21.60 | 101.95% |
Kita sa bawat share | — | — |
EBITDA | 14.25M | 125.39% |
Aktuwal na % ng binabayarang buwis | 0.82% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 39.20M | -70.33% |
Kabuuang asset | 111.26M | -49.36% |
Kabuuang sagutin | 72.13M | -14.92% |
Kabuuang equity | 39.13M | — |
Natitirang share | 208.65M | — |
Presyo para makapag-book | 6.39 | — |
Return on assets | 31.90% | — |
Return on capital | 54.46% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 10.67M | 110.25% |
Cash mula sa mga operasyon | 11.76M | 124.86% |
Cash mula sa pag-invest | 233.00K | -99.38% |
Cash mula sa financing | -203.00K | -103.00% |
Net change in cash | 12.92M | 225.19% |
Malayang cash flow | 10.99M | 134.43% |
Tungkol
Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. Wikipedia
CEO
Itinatag
1995
Headquarters
Website
Mga Empleyado
405
